Other: Oral Glucose tolerance test ( DrugBank: Glucose )

---

3 diseases

ID	Disease name (Link within this page)	Number of trials
160	Congenital ichthyosis	1
195	Noonan syndrome	1
299	Cystic fibrosis	3

160. Congenital ichthyosis

---

Clinical trials : 36 /  Drugs : 72 - (DrugBank : 21) / Drug target genes : 18 - Drug target pathways : 111

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02383316 (ClinicalTrials.gov)	January 2015	23/12/2014	Study of Metabolic Modifications in Children With Noonan Syndrome	Study of Metabolic Modifications in Children With Noonan Syndrome	Child Syndrome	Other: Oral Glucose tolerance test	University Hospital, Toulouse	NULL	Completed	7 Years	18 Years	All	20	N/A	France

195. Noonan syndrome

---

Clinical trials : 14 /  Drugs : 15 - (DrugBank : 5) / Drug target genes : 2 - Drug target pathways : 9

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02383316 (ClinicalTrials.gov)	January 2015	23/12/2014	Study of Metabolic Modifications in Children With Noonan Syndrome	Study of Metabolic Modifications in Children With Noonan Syndrome	Child Syndrome	Other: Oral Glucose tolerance test	University Hospital, Toulouse	NULL	Completed	7 Years	18 Years	All	20	N/A	France

299. Cystic fibrosis

---

Clinical trials : 1,696 /  Drugs : 1,644 - (DrugBank : 272) / Drug target genes : 96 - Drug target pathways : 170

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02398383 (ClinicalTrials.gov)	March 2015	22/1/2015	Role of Glucagon In Glucose Control in Cystic Fibrosis Related Diabetes	Role of Glucagon in Glucose Control in Cystic Fibrosis Related Diabetes	Cystic Fibrosis;Cystic Fibrosis Related Diabetes	Other: Oral Glucose Tolerance Test;Other: Mixed Meal Tolerance Test;Other: Hypoglycemic Clamp	Yale University	NULL	Completed	12 Years	45 Years	All	7	Early Phase 1	United States
2	NCT02202876 (ClinicalTrials.gov)	November 2014	25/7/2014	Redox Imbalance and the Development of Cystic Fibrosis Diabetes	Redox Imbalance and the Development of Cystic Fibrosis Diabetes	Diabetes Mellitus, Type 2;Cystic Fibrosis	Other: Oral Glucose Tolerance Test;Other: High Glycemic Index Meal;Other: Low Glycemic Index Meal;Other: Test Soda;Other: Fruit juice	Emory University	Cystic Fibrosis Foundation	Completed	1 Year	N/A	All	34	N/A	United States
3	NCT03644199 (ClinicalTrials.gov)	March 30, 2011	10/5/2016	Development of Diabetes in Adults With Cystic Fibrosis (CF)	Factors Responsible for the Development of Diabetes in Adults With Cystic Fibrosis	Cystic Fibrosis	Other: Oral Glucose Tolerance Test (OGTT) assessment arm;Other: Mixed meal test evaluation test arm	Liverpool Heart and Chest Hospital NHS Foundation Trust	NULL	Withdrawn	18 Years	50 Years	All	0	N/A	United Kingdom

Back to top